• Verona initiates Phase II trial for COPD powder inhaler pharmatimes
    December 18, 2018
    Verona has announced the start of a Phase II clinical trial to evaluate the pharmacokinetic profile, efficacy and safety of a dry powder inhaler (DPI) formulation of RPL554, for use in patients with moderate to severe...
PharmaSources Customer Service